Pharmacological profiles of SKP-450 and its family, a K+ channel opener, in comparison with levcromakalim

Pharmacological Research

Volumn 38, Issue 3, 1998, Pages 191-197

  Hong, Ki Whan ^a,b   Shin, Hwa Sup ^c   Kim, Chi Dae ^a   Shin, Yung Woo ^a   Yoo, Sung Eun ^c  

^a Pusan National University School of Medicine   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

86Rb efflux; Levcromakalim; SKP 450; Vasodepressor; Vasorelaxation

Indexed keywords

2 (1,3 DIOXOLAN 2 YL) 2 METHYL 6 NITRO 4 (2 OXO 1 PYRROLIDINYL) 2H 1 BENZOPYRAN; BENZOPYRAN DERIVATIVE; GLIBENCLAMIDE; LEMAKALIM; POTASSIUM CHANNEL STIMULATING AGENT; RUBIDIUM 86; SKP 310; SKP 818; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DOG; DRUG POTENCY; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION; VERTEBRAL ARTERY;

EID: 0032168505     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0352     Document Type: Article

References (17)

1. 1. Ashwood VA, Buckingham RE, Cassidy F, Evans JM, Faruk EA, Hamilton TC, Nash DJ, Stemp G, Willcocks K. Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyrans. J Med Chem 1986; 29: 2194-201
2. 2. Buckingham RE, Clapham JC, Coldwell MC, Hewlett DR, Hamilton TC. Stereospecific mechanism of action of the novel anti-hypertensive agent BRL 34915. Br J Pharmacol 1986; 87: 78P.
3. 3. Cavero I, Mondot S, Mestre M. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. J Pharmacol Exp Ther 1988; 248: 1261-8.
4. 4. Hof RP, Quast U, Cook NS, Blarer S. Mechanism of action and systemic and regional hemodynamics of the potassium channel activator BRL 34915 and its enantiomers. Circ Res 1988; 62: 679-86.
5. 5. Hamilton TC, Weir SW, Weston AH. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 1986; 88: 103-11.
6. 86Rb efflux in rabbit tonic vascular smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 1987; 335: R64.
7. + efflux in rat blood vessels. Br J Pharmacol 1986; 88: 121-8.
8. + channel. J Pharmacol Exp Ther 1995; 275: 807-12.
9. 9. Arunlakshana O, Schild HO. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 1959; 14: 48-58.
10. 10. Messing MW, Van-Essen H, Struyker-Boudier HA. Effects of alpha-adrenoceptor antagonists on striated muscle microcirculation of conscious rats. Drugs 1990; 40 (Suppl. 4): 31-3.
11. 11. Sato K, Kanatsuka H, Sekiguchi N, Akai K, Wang Y, Sugimura A, Kumagai T, Komaru T, Shirato K. Effect of an ATP-sensitive potassium channel opener levcromakalim on coronary arterial microvessels in the beating canine heart. Cardiovasc Res 1994; 28: 1780-6.
12. 12. Allen SL, Boyle GP, Cortijo J, Foster RW, Morgan GP, Small RC. Electrical and mechanical effects of BRL 34915 in guinea-pig isolated trachealis. Br J Pharmacol 1986; 89: 395-405.
13. + channel blocking agents on responses to BRL 34915 and pinacidil in the isolated rat portal vein. J Physiol 1988; 391: 77P.
14. 2+. J Physiol 1986; 374: 36P.
15. + efflux in dog coronary arteries. J Pharmacol Exp Ther 1990; 253: 586-93.
16. + channel openers diazoxide and cromakalim and their inhibition by glibenclamide. J Pharmacol Exp Ther 1989; 250: 261-71.
17. m. Stroke 1985; 16: 990-7.